Skip to content
★ Sign in to follow
刘

刘思川

Executive
科伦药业
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€1.5M
▼ Sales (0 ops.)
—

Latest filing published 12 Apr 2022 for 科伦药业, €238k.

Filing timeline

BuySale
刘思川

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
20%
Median T+90
-3.7%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 12 Apr 2022 · 1673 days ago · €238k
    +86.7%
    Entry CN¥16.00 · Close at T+365 CN¥29.87
  • Filed 15 Jul 2021 · 1944 days ago · €244k
    +3.8%
    Entry CN¥18.73 · Close at T+365 CN¥19.44
  • Filed 13 Jul 2021 · 1946 days ago · €250k
    -2.3%
    Entry CN¥19.17 · Close at T+365 CN¥18.72
  • Filed 08 Jul 2021 · 1951 days ago · €126k
    -1.6%
    Entry CN¥19.74 · Close at T+365 CN¥19.43
  • Filed 02 Jul 2021 · 1957 days ago · €651k
    -4.3%
    Entry CN¥19.94 · Close at T+365 CN¥19.08

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

刘思川: trading record in brief

刘思川, listed as chief executive, appears in our data through filings on 科伦药业 shares, published by SSE / SZSE (CSRC). Over a trading history stretching from 2 July 2021 to 12 April 2022, the count stands at 5 filings.

Every open-market trade on record is a purchase: 5 purchases worth €1.5M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2022 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €244k. Of 5 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 5 purchases with a full 90-day history, the hit rate stands at 20% and the median 90-day move at -3.7%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 12 April 2022 with an open-market purchase (€238k) in 科伦药业. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Companies and markets linked to 刘思川

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    董事,高管Executives科伦药业
    2M CNY9SZSE
    100,000 shares15.7% of flowA股XSHESZSE:173000005428776300
    Canonical exit: 11 Jul 2022 (T+90)
  • ▲
    董事,高管Executives科伦药业
    2M CNY24SZSE
    100,000 shares16.2% of flowA股XSHESZSE:173000004565785400
    Canonical exit: 13 Oct 2021 (T+90)
  • ▲
    董事,总经理Executives科伦药业
    2M CNY39SZSE
    100,000 shares16.6% of flowA股XSHESZSE:173000004560250750
    Canonical exit: 11 Oct 2021 (T+90)
  • ▲
    董事,总经理Executives科伦药业
    970,500 CNY38SZSE
    50,000 shares8.4% of flowA股XSHESZSE:173000004549240350
    Canonical exit: 6 Oct 2021 (T+90)
  • ▲
    董事,总经理Executives科伦药业
    5M CNY41SZSE
    253,900 shares43.1% of flowA股XSHESZSE:173000004537262750
    Canonical exit: 30 Sept 2021 (T+90)

5 of 5 declarations